CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 83 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $228,000 | +61.7% | 115,821 | +2.5% | 0.00% | – |
| Q4 2020 | $141,000 | -30.5% | 113,023 | 0.0% | 0.00% | – |
| Q3 2020 | $203,000 | -75.8% | 113,023 | +12.9% | 0.00% | -100.0% |
| Q2 2020 | $840,000 | +60.3% | 100,065 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $524,000 | +5.0% | 100,065 | +9.5% | 0.00% | 0.0% |
| Q4 2019 | $499,000 | +12.1% | 91,392 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $445,000 | -29.7% | 91,392 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $633,000 | +7.5% | 91,392 | +7.9% | 0.00% | 0.0% |
| Q1 2019 | $589,000 | +29.7% | 84,711 | +9.0% | 0.00% | 0.0% |
| Q4 2018 | $454,000 | -21.2% | 77,739 | +1.8% | 0.00% | 0.0% |
| Q3 2018 | $576,000 | +49.2% | 76,342 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $386,000 | -15.4% | 76,342 | +2.1% | 0.00% | 0.0% |
| Q1 2018 | $456,000 | -15.9% | 74,799 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $542,000 | +5.7% | 76,403 | +6.5% | 0.00% | 0.0% |
| Q3 2017 | $513,000 | +3.6% | 71,729 | -8.6% | 0.00% | 0.0% |
| Q2 2017 | $495,000 | – | 78,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |